Developer docs
API playgroundTry for free, no card

Search company profiles

VitaVitro Biotech

Full company profile

uuid0003dgp

Namestring
VitaVitro Biotech
Legal namestring
Shenzhen VitaVitro Biotech
Websiteurl
vitavitro.com
Company typeenum
Private
Founded yearint
2015
Descriptiontext

VitaVitro Biotech is a Shenzhen, China-headquartered medical device company founded in 2015 that develops, manufactures, and sells consumables and instruments for human in vitro fertilization (IVF) laboratories. Its product portfolio covers the full ART workflow, organized into cryopreservation systems (Open Pulled Straw vitrification, Vitrification and Warming Kits, Ultra-Fast Warming protocol), embryo culture systems (1-Step Culture Medium, Culture Oil, WOW Well-of-the-Well Dish, Humdish), IVF/ICSI media, sperm processing media, needles and catheters, and IVF dishes. The company's flagship Open Pulled Straw (OPS) vitrification technology, invented by Chief Scientific Advisor Prof. Gábor Vajta in 1998, is the most-cited method in mammalian embryo cryopreservation, achieving cooling/warming rates of approximately 20,000°C/min and producing the first human baby from vitrified oocytes.

The business operates a direct-to-fertility-clinic model with a single revenue stream from hardware and consumable sales. Pricing is not publicly disclosed and customers engage via the website contact form or direct outreach; VitaVitro supplements this with one-stop technical support and after-sales service, an in-house Academy, and the OPS mobile app for procedural coaching. Go-to-market is event-driven, anchored on six consecutive years of exhibition at ESHRE (2019-2024) and planned presence at ESHRE 2025 in Paris, plus regional conferences including the JSFG congress in Jordan (2024) marking Middle East entry. Manufacturing runs under GMP sanitation standards from the Shenzhen headquarters, with regulatory clearances spanning ISO 13485:2016, US QSR820, EU MDR 2017/745 (with CE certification for the cryopreservation system received in January 2025), and China NMPA, enabling sales in the United States (since 2019), Europe, China (since 2021), and select international markets.

Short descriptiontext

VitaVitro Biotech is a Shenzhen-based medical device company founded in 2015 that manufactures cryopreservation systems, embryo culture products, and consumables for human IVF laboratories worldwide, with FDA, CE, and NMPA regulatory clearances and a portfolio anchored by Prof. Gábor Vajta's OPS vitrification technology.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersShenzhen, China
HQ citystring
Shenzhen
HQ countrystring
China
HQ regionstring
Asia
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
IVF laboratory consumables, cryopreservation devices, embryo culture media, assisted reproduction supplies, ART medical devices
Industry1 code
PRIMARYHLAIAAAJ
Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals
NAICS code3 codes
  • Surgical Appliance and Supplies Manufacturing339113
  • Biological Product (except Diagnostic) Manufacturing325414
  • Surgical and Medical Instrument Manufacturing339112
SIC code2 codes
  • Surgical & Medical Instruments & Apparatus3841
  • Pharmaceutical Preparations2834
Product category
IVF Laboratory Medical Devices and Consumables
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model1 record
1Medical Devices and Consumables for IVF
TypeHardware Sales
Description

VitaVitro generates revenue through the sale of cryopreservation systems (OPS, vitrification/warming kits), embryo culture systems (culture media, culture oil, WOW dishes, Humdish), IVF/ICSI consumables (fertilization medium, gamete buffer medium, hyaluronidase), sperm processing products (sperm washing/gradient/freezing media), needles and catheters (oocyte retrieval needle, embryo transfer catheter, IUI catheter, micromanipulation pipettes), IVF dishes, and flushing buffer medium. Products are sold globally to human IVF laboratories with regulatory approvals in USA, Europe, China, and other markets.

vitavitro.com
Marketing channels6 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales
Pricing details1 tier
1B2B medical device and consumable sales to IVF laboratories
ModelOtherBilling cadencePay-as-you-go
Notes

Products are sold directly to IVF laboratories and clinics globally. No public pricing is available; customers contact the company directly. VitaVitro provides technical support and after-sales service as part of the customer relationship.

vitavitro.com
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 of 4 records shown
1VitaVitro OPS
Description

Open Pulled Straw vitrification system for cryopreservation of oocytes and embryos

vitavitro.com
+3 more records
Core offering1 text field

Shenzhen VitaVitro Biotech manufactures and supplies medical devices and consumables for human assisted reproductive technology (ART) and IVF laboratories. Its portfolio covers cryopreservation tools (open-pulled straw vitrification devices and vitrification/warming kits), embryo culture systems (culture media and dishes), sperm processing products, and procedural consumables such as needles, catheters and flushing buffer. The products are sold globally to fertility clinics, IVF laboratories and reproductive medicine centers.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • VitaVitro 1-step Culture Medium achieves fertilization rate of 71.2%, Day 5/6 blastocyst development rate of 58.9%, and clinical pregnancy rate of 68.89% in Chinese RCT (128 patients, 2,189 oocytes)
+4 more records
Product and service5 records
1OPS Vitrification Device
CategoryCryopreservation Devices
2Vitrification and Warming Kits
CategoryCryopreservation Consumables
3Embryo Culture Media and Dishes
CategoryEmbryo Culture Systems
4Sperm Processing Products
CategoryAndrology Consumables
5IVF/ICSI Needles, Catheters and Flushing Buffer
CategoryProcedural Consumables
Scale indicator3 records

Each record includes

Type, Value, Description, Source

Partnership2 partners
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-01-01
Description

University Hospital Bonn in Germany collaborated with VitaVitro on research demonstrating that slow-freezing ovarian tissue followed by rapid warming using VitaVitro Warming Kit achieves excellent clinical outcomes. The study showed 70% increase in primordial follicle preservation rate and 50% reduction in cell damage. Published in Reprod Biomed Online 2025.

2Dr. Lodovico Parmegiani
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2020-10-27
Description

Dr. Lodovico Parmegiani, Scientific Director of the Reproductive Medicine Center and Nextclinics International Group, Bologna, Italy, is a key collaborator with VitaVitro. The collaboration has produced 5 co-authored publications on vitrification and safe liquid nitrogen use, with a sixth opinion paper under consideration. Dr. Parmegiani is co-author on the 2025 study demonstrating ultra-fast warming protocol efficacy (Parmegiani L et al., Reprod Biomed Online 2025).

vitavitro.com
Recent move7 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
1Fertitech
TypeEmerging player
Description

Emerging ART consumables brand distributed in select markets, offering IVF media and microtools at competitive price points. Represents the type of regional/low-cost competitor VitaVitro increasingly encounters in emerging markets.

TypeDirect peer
Description

Swedish-listed global leader in IVF media, consumables, and time-lapse instruments. Directly comparable product portfolio (G-series media, Rapid-i vitrification, culture dishes) and customer base (human IVF labs), making it VitaVitro's closest large-scale competitor.

TypeDirect peer
Description

Australia-based ART device and media specialist (Geri's time-lapse incubator, Gems culture media). Closely aligned niche focus on IVF lab workflow with overlapping media and consumables categories.

TypeDirect peer
Description

Japanese ART consumables manufacturer best known for Cryotop vitrification, a direct competitor to VitaVitro's OPS and Vitrification/Warming Kit. Targets the same IVF laboratory buyers globally.

TypeBroad incumbent
Description

Division of FUJIFILM that manufactures cell culture media and ART consumables. Broad portfolio spans IVF, cell therapy, and industrial cell culture; competes with VitaVitro across media and cryopreservation.

TypeBroad incumbent
Description

Large diversified medical-device company with a comprehensive Fertility Solutions portfolio (Wallace catheters, media, microtools). Competes with VitaVitro across the full IVF consumables stack from a much broader corporate platform.

TypeDirect peer
Description

Singapore-based manufacturer of ART equipment (MIRI incubators, Mini-GTZ, time-lapse) and consumables. Closely aligned as an Asia-headquartered ART specialist targeting the same IVF lab customer segment.

TypeDirect peer
Description

German IVF media and consumables manufacturer with strong EU presence. Direct competitor in culture media, sperm processing media, and cryopreservation solutions targeting European fertility clinics.

TypeDirect peer
Description

UK-based medical device manufacturer with a dedicated ART product line (oocyte retrieval needles, embryo transfer catheters, IUI catheters). Overlaps VitaVitro's Needle & Catheter category.

10Merck KGaA (Sigma-Aldrich / EmbryoMax)
TypeBroad incumbent
Description

Global life-science giant offering EmbryoMax IVF media, cryopreservation reagents, and器械 consumables through its Sigma-Aldrich channel. Competes broadly with VitaVitro in culture media and cryo reagents.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature7 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles3 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds2 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

VitaVitro Biotech

IVF Laboratory Medical Devices and Consumablesvitavitro.com

VitaVitro Biotech is a Shenzhen-based medical device company founded in 2015 that manufactures cryopreservation systems, embryo culture products, and consumables for human IVF laboratories worldwide, with FDA, CE, and NMPA regulatory clearances and a portfolio anchored by Prof. Gábor Vajta's OPS vitrification technology.

What VitaVitro Biotech does

VitaVitro Biotech is a Shenzhen, China-headquartered medical device company founded in 2015 that develops, manufactures, and sells consumables and instruments for human in vitro fertilization (IVF) laboratories. Its product portfolio covers the full ART workflow, organized into cryopreservation systems (Open Pulled Straw vitrification, Vitrification and Warming Kits, Ultra-Fast Warming protocol), embryo culture systems (1-Step Culture Medium, Culture Oil, WOW Well-of-the-Well Dish, Humdish), IVF/ICSI media, sperm processing media, needles and catheters, and IVF dishes. The company's flagship Open Pulled Straw (OPS) vitrification technology, invented by Chief Scientific Advisor Prof. Gábor Vajta in 1998, is the most-cited method in mammalian embryo cryopreservation, achieving cooling/warming rates of approximately 20,000°C/min and producing the first human baby from vitrified oocytes.

The business operates a direct-to-fertility-clinic model with a single revenue stream from hardware and consumable sales. Pricing is not publicly disclosed and customers engage via the website contact form or direct outreach; VitaVitro supplements this with one-stop technical support and after-sales service, an in-house Academy, and the OPS mobile app for procedural coaching. Go-to-market is event-driven, anchored on six consecutive years of exhibition at ESHRE (2019-2024) and planned presence at ESHRE 2025 in Paris, plus regional conferences including the JSFG congress in Jordan (2024) marking Middle East entry. Manufacturing runs under GMP sanitation standards from the Shenzhen headquarters, with regulatory clearances spanning ISO 13485:2016, US QSR820, EU MDR 2017/745 (with CE certification for the cryopreservation system received in January 2025), and China NMPA, enabling sales in the United States (since 2019), Europe, China (since 2021), and select international markets.

VitaVitro Biotech firmographics

Firmographics
Name
VitaVitro Biotech
Legal name
Shenzhen VitaVitro Biotech
Website
https://vitavitro.com
Company type
Private
Founded year
2015
Operating status
Operating
Headcount range
11–50 employees
Short description
VitaVitro Biotech is a Shenzhen-based medical device company founded in 2015 that manufactures cryopreservation systems, embryo culture products, and consumables for human IVF laboratories worldwide, with FDA, CE, and NMPA regulatory clearances and a portfolio anchored by Prof. Gábor Vajta's OPS vitrification technology.
Ownership category
akta.pro rank

VitaVitro Biotech industry classification

Industry
Product category
IVF Laboratory Medical Devices and Consumables
NAICS
Surgical Appliance and Supplies Manufacturing (339113), Biological Product (except Diagnostic) Manufacturing (325414), Surgical and Medical Instrument Manufacturing (339112)
SIC
Surgical & Medical Instruments & Apparatus (3841), Pharmaceutical Preparations (2834)
akta.pro industry
PRIMARYHLAIAAAJ
Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health)
Healthcare & Life Sciences/Pharmaceuticals/Branded (Innovator) Pharmaceuticals

Keywords

  • IVF laboratory consumables
  • Cryopreservation devices
  • Embryo culture media
  • Assisted reproduction supplies
  • ART medical devices

Where VitaVitro Biotech is headquartered

Location

Headquarters

HQ city
Shenzhen
HQ country
China
HQ region
Asia

Offices1 record

Markets served

VitaVitro Biotech business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Personnel, Operations, Technology or R&D, Supply Chain, Marketing or Sales

Revenue model

  1. Medical Devices and Consumables for IVF: VitaVitro generates revenue through the sale of cryopreservation systems (OPS, vitrification/warming kits), embryo culture systems (culture media, culture oil, WOW dishes, Humdish), IVF/ICSI consumables (fertilization medium, gamete buffer medium, hyaluronidase), sperm processing products (sperm washing/gradient/freezing media), needles and catheters (oocyte retrieval needle, embryo transfer catheter, IUI catheter, micromanipulation pipettes), IVF dishes, and flushing buffer medium. Products are sold globally to human IVF laboratories with regulatory approvals in USA, Europe, China, and other markets.

Pricing tiers

ModelBillingPrice
OtherPay-as-you-goB2B medical device and consumable sales to IVF laboratories

Go-to-market motion2 records

Distribution channels2 records

Marketing channels6 records

VitaVitro Biotech product offering

Product offering

Core offering

Shenzhen VitaVitro Biotech manufactures and supplies medical devices and consumables for human assisted reproductive technology (ART) and IVF laboratories. Its portfolio covers cryopreservation tools (open-pulled straw vitrification devices and vitrification/warming kits), embryo culture systems (culture media and dishes), sperm processing products, and procedural consumables such as needles, catheters and flushing buffer. The products are sold globally to fertility clinics, IVF laboratories and reproductive medicine centers.

Differentiator

Problem solved

Functional benefit

Brands

  • VitaVitro OPS: Open Pulled Straw vitrification system for cryopreservation of oocytes and embryos
  • VitaVitro Cryopreservation System
  • WOW (Well-of-the-Well) Dish
  • Humdish

Products and services

  • OPS Vitrification Device
  • Vitrification and Warming Kits
  • Embryo Culture Media and Dishes
  • Sperm Processing Products
  • IVF/ICSI Needles, Catheters and Flushing Buffer

Quantifiable outcome

  • VitaVitro 1-step Culture Medium achieves fertilization rate of 71.2%, Day 5/6 blastocyst development rate of 58.9%, and clinical pregnancy rate of 68.89% in Chinese RCT (128 patients, 2,189 oocytes)
  • +4 more outcomes

Companies that use VitaVitro Biotech

Customer profile

Segments1 record

Ideal customer profiles1 record

VitaVitro Biotech technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature7 records

VitaVitro Biotech partnerships and signals

Strategic signal

Partnerships

Two partnerships are on record, tiered core.

  • University Hospital Bonn (Germany)coreStrategic or Co-development Partner · 1 January 2025University Hospital Bonn in Germany collaborated with VitaVitro on research demonstrating that slow-freezing ovarian tissue followed by rapid warming using VitaVitro Warming Kit achieves excellent clinical outcomes. The study showed 70% increase in primordial follicle preservation rate and 50% reduction in cell damage. Published in Reprod Biomed Online 2025.
  • Dr. Lodovico ParmegianicoreStrategic or Co-development Partner · 27 October 2020Dr. Lodovico Parmegiani, Scientific Director of the Reproductive Medicine Center and Nextclinics International Group, Bologna, Italy, is a key collaborator with VitaVitro. The collaboration has produced 5 co-authored publications on vitrification and safe liquid nitrogen use, with a sixth opinion paper under consideration. Dr. Parmegiani is co-author on the 2025 study demonstrating ultra-fast warming protocol efficacy (Parmegiani L et al., Reprod Biomed Online 2025).

Scale indicators3 records

Recent moves7 records

Expansion highlights5 records

VitaVitro Biotech competitors and assessment

Company assessment

Emerging players

  • Fertitech: Emerging ART consumables brand distributed in select markets, offering IVF media and microtools at competitive price points. Represents the type of regional/low-cost competitor VitaVitro increasingly encounters in emerging markets.

Direct peers

  • Vitrolife: Swedish-listed global leader in IVF media, consumables, and time-lapse instruments. Directly comparable product portfolio (G-series media, Rapid-i vitrification, culture dishes) and customer base (human IVF labs), making it VitaVitro's closest large-scale competitor.
  • Genea Biomedx: Australia-based ART device and media specialist (Geri's time-lapse incubator, Gems culture media). Closely aligned niche focus on IVF lab workflow with overlapping media and consumables categories.
  • Kitazato Corporation: Japanese ART consumables manufacturer best known for Cryotop vitrification, a direct competitor to VitaVitro's OPS and Vitrification/Warming Kit. Targets the same IVF laboratory buyers globally.
  • Esco Medical: Singapore-based manufacturer of ART equipment (MIRI incubators, Mini-GTZ, time-lapse) and consumables. Closely aligned as an Asia-headquartered ART specialist targeting the same IVF lab customer segment.
  • Gynemed: German IVF media and consumables manufacturer with strong EU presence. Direct competitor in culture media, sperm processing media, and cryopreservation solutions targeting European fertility clinics.
  • Rocket Medical: UK-based medical device manufacturer with a dedicated ART product line (oocyte retrieval needles, embryo transfer catheters, IUI catheters). Overlaps VitaVitro's Needle & Catheter category.

Broad incumbents

  • FUJIFILM Irvine Scientific: Division of FUJIFILM that manufactures cell culture media and ART consumables. Broad portfolio spans IVF, cell therapy, and industrial cell culture; competes with VitaVitro across media and cryopreservation.
  • CooperSurgical (Fertility Solutions): Large diversified medical-device company with a comprehensive Fertility Solutions portfolio (Wallace catheters, media, microtools). Competes with VitaVitro across the full IVF consumables stack from a much broader corporate platform.
  • Merck KGaA (Sigma-Aldrich / EmbryoMax): Global life-science giant offering EmbryoMax IVF media, cryopreservation reagents, and器械 consumables through its Sigma-Aldrich channel. Competes broadly with VitaVitro in culture media and cryo reagents.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights7 records

Customer concentration

VitaVitro Biotech social profiles

Digital presence

VitaVitro Biotech financial estimates

Financial estimate

Revenue estimate

Valuation estimate

VitaVitro Biotech leadership team

Management profile

Number of profiles

Profiles3 records

VitaVitro Biotech funding detail

Funding detail

Funding overview

Funding rounds2 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

VitaVitro Biotech M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about VitaVitro Biotech

What does VitaVitro Biotech do?

Shenzhen VitaVitro Biotech manufactures and supplies medical devices and consumables for human assisted reproductive technology (ART) and IVF laboratories. Its portfolio covers cryopreservation tools (open-pulled straw vitrification devices and vitrification/warming kits), embryo culture systems (culture media and dishes), sperm processing products, and procedural consumables such as needles, catheters and flushing buffer. The products are sold globally to fertility clinics, IVF laboratories and reproductive medicine centers.

Is VitaVitro Biotech a public or private company?

VitaVitro Biotech is a private company. It is classified as venture growth investor backed and is currently operating.

When was VitaVitro Biotech founded?

VitaVitro Biotech was founded in 2015. It employs 11 to 50 people.

Where is VitaVitro Biotech based?

VitaVitro Biotech is headquartered in Shenzhen, China, in the Asia region.

How does VitaVitro Biotech make money?

One revenue line is on record: medical Devices and Consumables for IVF.

Who are VitaVitro Biotech's main competitors?

Fertitech is listed as an emerging player. Direct peers are Vitrolife, Genea Biomedx, Kitazato Corporation, Esco Medical, Gynemed and Rocket Medical. Broad incumbents are FUJIFILM Irvine Scientific, CooperSurgical (Fertility Solutions) and Merck KGaA (Sigma-Aldrich / EmbryoMax).

Does VitaVitro Biotech have an API?

No public API is recorded for VitaVitro Biotech.

What industry is VitaVitro Biotech in?

VitaVitro Biotech's product category is IVF Laboratory Medical Devices and Consumables. Its primary akta.pro industry code is HLAIAAAJ, Endocrinology & Reproductive Health Pharmaceuticals (incl. Women’s Health). Its NAICS code is 339113 and its SIC code is 3841.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales